|Articles|December 1, 1996

November/December 1996
Volume 2
Issue 11

Implementation of a Clinical Pathway for Cesarean Section

Author(s)Scott B. Ransom, DO, James W. Gell, MD, Mathew Harrison

Download PDF: Implementation of a Clinical Pathway for Cesarean Section

Articles in this issue

almost 29 years ago

Article

The Year in Review

almost 29 years ago

Article

Coverage Decisions for Medical Technology by Managed Care: Relationship to Organizational and Physician Payment Characteristics

almost 29 years ago

Article

Childhood Immunizations: Beyond HEDIS

almost 29 years ago

Article

Six HMOs in Search of a Study: Comments on Two Papers by Horn et al

almost 29 years ago

Article

Homecare Therapy: A Cost-Effective Alternative Approach to the Management of Advanced Heart Failure

almost 29 years ago

Article

The Cholesterol Population Model: US Population Requirements for Treatment of Hypercholesterolemia

almost 29 years ago

Article

The Economic and Health-Related Quality of Life Impact of Epilepsy

almost 29 years ago

Article

Telecomputing as a Tool to Increase Consumer Participation in Managed Care

almost 29 years ago

Article

Impact of Oral Sumatriptan on Workplace Productivity, Health-Related Quality of Life, Healthcare Use, and Patient Satisfaction with Medication in Nurses with Migraine

almost 29 years ago

Article

Disease Management: Has Anyone Managed to Make It Work?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual Care

ByPooja Gokhale, PharmD,Lorenzo Villa Zapata, PhD

November 18th 2025

Evaluating Racial Concordance in a Telephonic Care Management Program Among Black Patients

ByMelanie Canterberry, PhD,Aina Katsikas, PhD,Amanda K. Sutherland, PhD,Yong Li, PhD,Emily Boudreau, PhD,Brian W. Powers, MD, MBA

November 17th 2025

Insurance-Related Differences in Chronic Conditions Data Warehouse Comorbidities of Medicare Beneficiaries

ByJustin M. Schaffer, MD,John J. Squiers, MD,Austin Kluis, MD,Jasjit K. Banwait, PhD,Mario F. L. Gaudino, MD, PhD,Michael J. Mack, MD,J. Michael DiMaio, MD

November 14th 2025

US Spending on High-Revenue Rare Disease Drugs in 2022

ByHelen Mooney, MPH,Aaron S. Kesselheim, MD, JD, MPH,Benjamin N. Rome, MD, MPH

November 14th 2025

Clinical Setting of Initial Psychotic Spectrum Disorder Diagnoses in an Integrated Health System

ByChristyn Haigler, MD,Andrea H. Kline-Simon, MS,Matthew E. Hirschtritt, MD, MPH,Icelini Stavers-Sosa, MD

November 14th 2025

Implementation of a Clinical Pathway for Cesarean Section

Articles in this issue

Newsletter

Related Content

Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual Care

Evaluating Racial Concordance in a Telephonic Care Management Program Among Black Patients

Insurance-Related Differences in Chronic Conditions Data Warehouse Comorbidities of Medicare Beneficiaries

US Spending on High-Revenue Rare Disease Drugs in 2022

Clinical Setting of Initial Psychotic Spectrum Disorder Diagnoses in an Integrated Health System

Trending on AJMC

Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS

Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL

Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer

The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD

Faricimab Brought Early Control of Some Symptoms in AMD